Skip to main content
Galenica AG logo

Galenica AG — Investor Relations & Filings

Ticker · GALE ISIN · CH0360674466 LEI · 506700W4772BD8016Z20 SW Wholesale and retail trade
Open in API
Filings indexed 117 across all filing types
Latest filing 2026-03-12 Regulatory Filings
Country CH Switzerland
Listing SW GALE

About Galenica AG

https://www.galenica.com/en/index.php

Galenica AG is an integrated healthcare provider that operates a comprehensive network of companies. The group's core activities encompass pharmaceutical logistics and distribution, alongside the management of an extensive network of over 500 owned, joint venture, and partner pharmacies. Through its more than 20 business units, the company aims to deliver seamless, efficient, and personalized services to patients and customers. Galenica also develops digital healthcare solutions and offers a range of other healthcare services and products, positioning itself as a key partner in the healthcare market.

Recent filings

Filing Released Lang Actions
Konsultationsverfahren bei Bichsel abgeschlossen
Regulatory Filings Classification · 95% confidence The document is a press release (Medienmitteilung) from Galenica AG regarding the closure of a pharmaceutical production facility at their subsidiary, Bichsel, following a consultation process. It details the impact on staff, the social plan, and customer support. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple announcement of a report publication (RPA). As it is a general corporate announcement regarding business operations and restructuring, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2026-03-12 German
Galenica achieves strong annual result and increases mid-term guidance
Earnings Release Classification · 100% confidence The document is an 'ad hoc announcement' regarding Galenica's 2025 annual financial results. It provides key highlights such as sales growth, EBIT figures, and future guidance, and explicitly directs readers to the full 'Annual Report 2025' via a link. Since this is a summary announcement of financial results rather than the full 10-K report itself, it is classified as an Earnings Release. FY 2025
2026-03-10 English
Galenica réalise un excellent résultat annuel et revoit à la hausse ses prévisions à moyen terme
Earnings Release Classification · 100% confidence The document is a press release titled 'Communiqué de presse' announcing the annual financial results for Galenica AG for the year 2025. It provides key financial highlights (revenue, EBIT, net profit), strategic updates, and forward-looking guidance. It explicitly mentions that the full 'Rapport annuel 2025' (Annual Report) is available via a link, confirming this document is the initial earnings announcement rather than the full report itself. Therefore, it is classified as an Earnings Release. FY 2025
2026-03-10 French
Galenica achieves strong annual result and increases mid-term guidance
Earnings Release Classification · 95% confidence The document is an 'ad hoc announcement' regarding annual results. It provides key financial highlights, guidance, and performance metrics, but explicitly directs the reader to the full 'Annual Report 2025' via a link. Because it is a summary announcement of financial results rather than the full report itself, and it follows the standard format for an earnings release (key highlights, management commentary, and upcoming conference details), it is classified as an Earnings Release. FY 2025
2026-03-10 English
Galenica realisiert starkes Jahresergebnis und erhöht Mittelfristguidance
Earnings Release Classification · 100% confidence The document is an 'Ad hoc-Mitteilung' (Ad hoc announcement) from Galenica AG regarding their annual financial results for 2025. It provides key financial highlights, performance metrics, and future guidance. Crucially, it explicitly states 'Weiterführende Informationen sind im Geschäftsbericht 2025 enthalten' (Further information is contained in the 2025 Annual Report) and provides links to the full report. Since this is a summary announcement of financial results rather than the full annual report itself, it is classified as an Earnings Release. FY 2025
2026-03-10 German
Galenica focuses Bichsels business on home care services
Regulatory Filings Classification · 95% confidence The document is an 'ad hoc' announcement released by Galenica AG regarding a strategic business decision to discontinue a pharmaceutical production division. It contains specific details about the operational impact, job losses, and financial implications (special costs). Since it does not fit into specific categories like earnings releases, annual reports, or director dealings, and is a formal regulatory disclosure of material information, it is classified as a Regulatory Filing (RNS).
2026-02-24 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.